GlobeNewsWire
22 Jul 2026, 15:45 UTC · 2h ago
Valneva to Report First Half 2026 Consolidated Financial Results on August 13, 2026
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
GlobeNewsWire
22 Jul 2026, 15:45 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
Valneva will report its first half 2026 consolidated financial results on August 13, 2026. — Earnings dates create catalysts for volatility, though the mere announcement of a date is low-impact.
+0.10Which stocks this story touches
Pfizer is mentioned only as a partner in a vaccine candidate without any new developments or performance data.
The article is a routine administrative announcement regarding upcoming financial results and a board appointment.
Continue reading
6 related stories
Top 1 mover · tap to explore
[mutual] Valneva has partnered with Pfizer on its Lyme disease vaccine candidate.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Zacks Investment Research
1h ago
